Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)
CNY 46.57
(-0.04%)
CNY 46.57
(-0.04%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 22.81 Billion | 21.27 Billion | 25.9 Billion | 27.73 Billion | 23.28 Billion | 17.41 Billion |
| Cost of Revenue | 3.52 Billion | 3.48 Billion | 3.74 Billion | 3.34 Billion | 2.91 Billion | 2.33 Billion |
| Gross Profit | 19.29 Billion | 17.78 Billion | 22.16 Billion | 24.38 Billion | 20.37 Billion | 15.08 Billion |
| Operating Expenses | 14.38 Billion | 14.44 Billion | 18.08 Billion | 17.9 Billion | 14.68 Billion | 10.83 Billion |
| Selling, General and Administrative Expenses | 8.98 Billion | 9.09 Billion | 11.43 Billion | 12.02 Billion | 10.07 Billion | 7.46 Billion |
| Research and Development Expenses | 4.95 Billion | 4.88 Billion | 5.94 Billion | 4.98 Billion | 3.89 Billion | 2.67 Billion |
| Other Expenses | 442.73 Million | 458.68 Million | 697.9 Million | 888.68 Million | 717.71 Million | -97.57 Million |
| Cost and Expenses | 17.9 Billion | 17.93 Billion | 21.82 Billion | 21.25 Billion | 17.6 Billion | 13.16 Billion |
| Operating Income | 4.9 Billion | 4.11 Billion | 4.66 Billion | 7 Billion | 6.14 Billion | 4.59 Billion |
| Interest Expense | 6.65 Million | 6.49 Million | 4.71 Million | 5.49 Million | 6.88 Million | 4.77 Million |
| Income Tax Expense | 389.28 Million | 153.42 Million | -17.71 Million | 586.58 Million | 729.3 Million | 437.89 Million |
| Earnings before Tax | 4.66 Billion | 3.96 Billion | 4.46 Billion | 6.89 Billion | 6.05 Billion | 4.49 Billion |
| Net Income | 4.3 Billion | 3.9 Billion | 4.53 Billion | 6.32 Billion | 5.32 Billion | 4.06 Billion |
| Earnings Per Share Basic | 0.68 | 0.61 | 0.71 | 1.00 | 0.84 | 0.64 |
| Earnings Per Share Diluted | 0.68 | 0.61 | 0.71 | 1.00 | 0.84 | 0.63 |
| Weighted Average Shares Outstanding | 6.32 Billion | 6.36 Billion | 6.38 Billion | 6.35 Billion | 6.33 Billion | 6.36 Billion |
| Weighted Average Shares Outstanding (Diluted) | 6.32 Billion | 6.36 Billion | 6.38 Billion | 6.35 Billion | 6.33 Billion | 6.43 Billion |
| Gross Margin | 0.85 | 0.84 | 0.86 | 0.88 | 0.87 | 0.87 |
| EBIT Margin | 0.24 | 0.22 | 0.20 | 0.27 | 0.29 | 0.28 |
| Profit Margin | 0.19 | 0.18 | 0.17 | 0.23 | 0.23 | 0.23 |
| EBITDA | 5.54 Billion | 4.68 Billion | 5.02 Billion | 7.37 Billion | 6.68 Billion | 4.88 Billion |
| Earnings Before Tax Margin | 0.22 | 0.19 | 0.18 | 0.25 | 0.26 | 0.26 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 6.58 Billion | 7.54 Billion | 5.99 Billion | 22.81 Billion | 5.8 Billion | 5.84 Billion |
| Cost of Revenue | 959.87 Million | 1.01 Billion | 942.84 Million | 3.52 Billion | 867.69 Million | 888.18 Million |
| Gross Profit | 5.62 Billion | 6.52 Billion | 5.05 Billion | 19.29 Billion | 4.93 Billion | 4.95 Billion |
| Operating Expenses | 4.33 Billion | 4.5 Billion | 3.56 Billion | 14.66 Billion | 3.94 Billion | 3.67 Billion |
| Selling, General and Administrative Expenses | 4.3 Billion | 2.77 Billion | 2.34 Billion | - | 1.9 Billion | 2.73 Billion |
| Research and Development Expenses | 1.51 Billion | 1.74 Billion | 1.22 Billion | - | 1.22 Billion | 1.39 Billion |
| Other Expenses | -1.48 Billion | 15.7 Million | -133.49 Million | -242.79 Million | -113.84 Million | -75.86 Million |
| Cost and Expenses | 5.29 Billion | 5.52 Billion | 4.5 Billion | 18.19 Billion | 4.8 Billion | 4.56 Billion |
| Operating Income | 1.36 Billion | 2.01 Billion | 1.63 Billion | 4.9 Billion | 968.57 Million | 1.37 Billion |
| Interest Expense | - | 3.31 Million | - | 5.9 Million | 1.16 Million | 1.05 Million |
| Income Tax Expense | 146.94 Million | 188.44 Million | 135.02 Million | 389.28 Million | 27.94 Million | 139.3 Million |
| Earnings before Tax | 1.33 Billion | 2.28 Billion | 1.5 Billion | 4.66 Billion | 854.73 Million | 1.29 Billion |
| Net Income | 1.18 Billion | 2.06 Billion | 1.36 Billion | 4.3 Billion | 828.65 Million | 1.16 Billion |
| Earnings Per Share Basic | 0.19 | 0.32 | 0.21 | - | 0.13 | 0.18 |
| Earnings Per Share Diluted | 0.19 | 0.32 | 0.21 | - | 0.13 | 0.18 |
| Weighted Average Shares Outstanding | 6.34 Billion | 6.34 Billion | 6.51 Billion | 6.32 Billion | 6.35 Billion | 6.35 Billion |
| Weighted Average Shares Outstanding (Diluted) | 6.34 Billion | 6.34 Billion | 6.51 Billion | 6.32 Billion | 6.35 Billion | 6.35 Billion |
| Gross Margin | 0.85 | 0.86 | 0.84 | 0.85 | 0.85 | 0.85 |
| EBIT Margin | 0.20 | 0.30 | 0.25 | - | 0.16 | 0.23 |
| Profit Margin | 0.18 | 0.27 | 0.23 | 0.19 | 0.14 | 0.20 |
| EBITDA | 1.33 Billion | 2.23 Billion | 1.49 Billion | - | 953.93 Million | 1.33 Billion |
| Earnings Before Tax Margin | 0.21 | 0.27 | 0.27 | 0.22 | 0.17 | 0.23 |
4651
DYA
6797
FACORALL
ISI
SRBIF